Fueling bold approaches

Flu Lab's mission is to eliminate the threat of influenza, a highly contagious virus that causes annual epidemics of disease and poses an ever-present risk of a catastrophic pandemic. To achieve this, Flu Lab finds and supports efforts that approach persistent problems in new and dynamic ways, with actionable results.

Through grantmaking, investing, and partner collaborations, Flu Lab seeks to help grantees and early-stage companies develop innovations that will help accelerate the availability of new solutions for global influenza challenges.

Awarded Grants and Investments

We are pleased to showcase past and current grantees and investments. For news and updates about our grants and investments, visit News + More.

WUStL3line(RGB)1000-01.png

Washington University in St. Louis

Creating a handheld, rapid result, breath-based diagnostic for the detection of multiple respiratory pathogens.

$3,595,280 / November 2023

Panoplia_logo_vertical.png

Panoplia Labs

Developing inhalable, broad-spectrum antivirals that provide extended prophylaxis against infectious diseases.

$159,000 / October 2023

Pictura_Bio_Horizontal_Logo.png

PicturaBio

Creating the first universal testing platform to provide fast, accurate, digital imaging-based identification for infectious disease pathogens.

Seed / October 2023

Versatope.Engineering Immunity-2.png

Versatope

Investigating, in ferrets against H3N2, the sterilizing immunity potential of an intranasal universal influenza vaccine construct.

$59,215 / July 2023

28_informalseal.png

Fishell Institute for Biomedical Devices

  • Adapting graphene-based biosensors for the selective detection of influenza.

  • $1,348,454 / June 2023

EU_shield_hz_280.png

Emory University

Establishing a reproducible, experimental human infection model of influenza virus transmission and evaluating interventions.

$3,479,305 / March 2023

Logo3.jpg

University of Oxford

Evaluating treatments for severe and complicated influenza infections in hospitalized patients with RECOVERY FLU, a cost-efficient, adaptive platform clinical trial.

£11,416,263 / December 2022

Screen-Shot-2023-03-03-at-1.30.13-PM.jpeg

Kansas State University and Icahn School of Medicine

Establishing a swine herd model for assessing the efficacy of broadly protective influenza virus vaccines.

$1,652,929 / December 2022

uoa.png

University of Auckland

Leads a multidisciplinary and collaborative effort to observe and examine the reintroduction and transmission of influenza in New Zealand and identify novel immunological markers to inform influenza vaccine development.

11,340,572 NZD / December 2022, May 2021

detect.jpg

Detect

Developing fast, accurate, and affordable molecular tests for routine use by everyone, including consumers in the home, employees in the workplace, and students at school.

Series C / November 2022, Series B / April 2021

RM + AUH UK logo ver2.jpg

Aarhus University Hospital

Leads INVITED, a multicenter, prospective randomized clinical trial among Type 1 diabetes patients to improve our understanding of the protective effect of influenza vaccination.

2,382,555 DKK / October 2022

Protas_Logo_900_x_450px copy.jpg

Protas

Reducing barriers to better treatments by designing and delivering high-quality, large-scale and global clinical trials at a fraction of current industry cost.

£5,000,000 / October 2022

8-0RxYdl.png

NYC Virus Hunters

Creates an immersive approach to science education to unlock the potential of the next generation of influenza researchers in New York City.

$1,146,303 / July 2022, April 2020

Univ. of PA.png

Behavior Change for Good Initiative

Leverages the expertise of over 100 behavioral scientists to identify effective, scalable interventions for promoting immunizations.

$2,435,763 / March 2022, June 2021, October 2020

Horizontal_VT_Full_Color_RGB.jpg

Virgina Tech

Leads the Multidisciplinary InvesTIGAtion of Transmission to Ease inFLUenza (MITIGATE FLU) study to transform our understanding of influenza virus transmission.

$8,792,291 / February 2022

expanded_logo_gold-blue.png

University of California, Davis

Optimizing ventilation system operations to minimize airborne infectious disease transmission, pollutant exposure, and energy consumption.

$327,539 / November 2021

green schools.png

Center for Green Schools

Equips schools and education stakeholders with information and guidance to improve ventilation and air filtration in classrooms.

$855,710 / October 2021, August 2021

Center_for_Open_Science_logo_sm.original.png

Center for Open Science

Leads multiple initiatives to promote open science and expand the publication of null and negative influenza research findings and replication studies.

$18,398,983 / August 2021, April 2020, August 2019

sabin.png

Influenzer Initiative

Brings diverse thinkers and disciplines together to identify big ideas and promote pathways to accelerating universal influenza vaccine development.

$8,900,000 / June 2021, January 2018

University_of_Cambridge_logo_logotype.png

University of Cambridge

Pursuing a novel, host-directed approach to a universal influenza vaccine.

$904,384 / June 2021

AIM_Logo_RGB.png

Association of Immunization Managers

Brought together immunization managers and school nurses to identify replicable best practices for school-located vaccination programs.

$208,035 / June 2021

gpp_logo.png

The Grand Challenge for Universal Influenza Vaccine Development

Supports eight teams developing novel, transformative approaches to universal influenza vaccines (in partnership with the Bill & Melinda Gates Foundation)

$6,215,453 / April 2021, January 2021, August 2019

28_informalseal.png

Public Health Aerobiology, Virology, and Exhaled Biomarker Lab

Leads a research agenda centered on influenza transmission and the interplay between influenza and SARS-CoV-2 viruses.

$2,539,000 / March 2021

BroadInstLogoforDigitalRGB.png

Sentinel Project

Develops ultra-sensitive genomic and CRISPR technologies to detect pathogens in multiple, connected settings to prevent pandemics before they start.

$5,000,000 / February 2021

African center.jpg

Sentinel Project

Combines diagnostic technology and information-sharing platforms to connect early warning data to the public health community.

$11,250,000 / December 2020

195-1957960_imperial-college-london-logo-vector.png

Imperial College London and Princeton University

Assessing performance characteristics and market dynamics of universal influenza vaccines using mathematical modeling methods.

$381,199 / November 2020

Stanford_Medicine_V-web.png

Stanford Healthcare Innovation Lab

Demonstrated the utility of wearables for early disease signaling, before symptoms emerge.

$1,870,000 / October 2020, August 2020

1200px-Boston_Children's_Hospital_logo.svg.png

Outbreaks Near Me

Provides a crowdsourced infectious disease surveillance system to provide early outbreak warnings for communities and local public health agencies.

$1,005,451 / August 2020

the-university-of-chicago-vector-logo-small.png

RECOVER Project

Developed and examined a novel strategy for disease surveillance that improves representativeness of population samples.

$230,000 / August 2020

1280px-University_of_California,_Berkeley_logo.svg.png

Berkeley, Public Health

Evaluated the direct and indirect health impacts of a school-based seasonal influenza vaccination program in the Bay Area.

$278,422 / August 2020, February 2020, February 2019

logo-(3).png

Community Epidemiology in Action

Created an open source, anonymous, privacy-first symptom sharing and exposure alerting application to help communities of close contacts protect themselves.

$100,000 / May 2020

logo@2x-(1).png

Greenlight Biosciences

Offers an inexpensive, self-contained, and scalable mRNA manufacturing platform for vaccines targeting infectious diseases, including influenza and COVID-19.

Special purpose funding round / May 2020 (Exited)

Funding Opportunities

Flu Lab promotes innovation to speed the advancement of technologies and approaches for influenza, and we are open to receiving unsolicited pre-proposals at info@theflulab.org.